Sign in

CIK 0001674416 · Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
EIN
473173478
Phone
6173154600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kulkarni Samarth −$2.6M Chief Executive Officer sold 14% of stake
  2. KASINGER JAMES R. −$797K General Counsel and Secretary sold 12% of stake
  3. Behbahani Ali −$781K Director sold 45% of stake
  4. George Simeon −$720K Director sold 48% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-01-15 Klein Lawrence Otto CBO & COO Option exercise · Stock Option (Right to Buy) −8,666 0
2021-01-15 Klein Lawrence Otto CBO & COO Option exercise · Stock Option (Right to Buy) −16,334 14,666
2021-01-02 Klein Lawrence Otto CBO & COO Shares withheld for taxes −9,392 $153.11 $1.4M 10,608
2020-12-29 Kulkarni Samarth Chief Executive Officer Option exercise +13,800 $1.81 $25K 182,989
2020-12-29 Kulkarni Samarth Chief Executive Officer Option exercise · Stock Option (right to buy) −13,800 128,983
2020-12-21 Ho Tony W Executive VP, Head of R&D Option exercise +23,551 $16.90 $398K 57,515
2020-12-21 Ho Tony W Executive VP, Head of R&D Sale −1,700 $148.11 $252K 55,815
2020-12-21 Ho Tony W Executive VP, Head of R&D Sale −900 $149.18 $134K 54,915
2020-12-21 Ho Tony W Executive VP, Head of R&D Sale −1,600 $150.16 $240K 53,315
2020-12-21 Ho Tony W Executive VP, Head of R&D Sale −1,100 $151.58 $167K 52,215
2020-12-21 Ho Tony W Executive VP, Head of R&D Sale −500 $152.41 $76K 51,715
2020-12-21 Ho Tony W Executive VP, Head of R&D Sale −1,400 $147.05 $206K 50,315
2020-12-21 Ho Tony W Executive VP, Head of R&D Sale −8,400 $148.38 $1.2M 41,915
2020-12-21 Ho Tony W Executive VP, Head of R&D Sale −5,000 $149.73 $749K 36,915
2020-12-21 Ho Tony W Executive VP, Head of R&D Sale −2,951 $150.61 $444K 33,964
2020-12-21 Ho Tony W Executive VP, Head of R&D Option exercise · Stock Option (right to buy) −23,551 236,449
2020-12-16 Bolzon Bradley J PhD Director Sale −914 $147.00 $134K 6,734
2020-12-16 Bolzon Bradley J PhD Director Sale −878 $147.00 $129K 346,308
2020-12-16 Bolzon Bradley J PhD Director Sale −2,679 $148.28 $397K 4,055
2020-12-16 Bolzon Bradley J PhD Director Sale −2,576 $148.28 $382K 343,732

Page 35 of 46 · 910 trades